News | IMMUPHARMA (IMM.L, LSE, LSE:IMM)

Latest News

FTSE 100 makes strong recovery

Leading London shares made a strong recovery today following yesterday's declines despite worse than expected UK Gover...

FTSE 100 bounces back

FTSE indices bounced back this morning following yesterday's declines despite worse than expected UK Government borr...

ImmuPharma raises £3.4m

ImmuPharma, the specialist drug discovery and development company, has conditionally raised approximately 3.4m. This ...

Additional Listing - Conditional Placing

Notification of any addition to a company’s existing share capital

All News

DateHeadlineSource
21-10-14FTSE 100 makes strong recoveryStockMarketWire
21-10-14FTSE 100 bounces backStockMarketWire
21-10-14ImmuPharma raises £3.4m StockMarketWire
21-10-14Additional Listing - Conditional PlacingRNS
20-10-14ImmuPharma unit awarded €400,000 grant StockMarketWire
20-10-14ImmuPharma awarded EUR400,000 GrantRNS
30-09-14Losses remain at ImmuPharmaStockMarketWire
30-09-14Half Yearly ReportRNS
30-09-14LupuzorT Gears Up To Start Pivotal Phase III trialRNS
27-06-14Immupharma shareholders approve AGM resolutionsStockMarketWire
27-06-14Result of AGMRNS
27-06-14ImmuPharma extends research capabilitiesStockMarketWire
27-06-14Access to pioneering research in Bordeaux FranceRNS
16-06-14ImmuPharma granted new Nucant patents StockMarketWire
16-06-14NEW NUCANT PATENTSRNS
23-05-14Annual Financial ReportRNS
21-05-14ImmuPharma pre-tax losses riseStockMarketWire
21-05-14Preliminary ResultsRNS
06-05-14ImmuPharma gives summary from lupus conference StockMarketWire
06-05-14Dr. Sylviane Muller - Presentation AbstractRNS
23-04-14Lupuzor founder presents at Osaka UniversityStockMarketWire
23-04-14Dr. S Muller, founder of Lupuzor presentation.RNS
11-04-14ImmuPharma Sponsors the 2014 European Lupus ConferRNS
14-10-13Additional ListingRNS
27-09-13ImmuPharma trims operating lossStockMarketWire
27-09-13Half Yearly ReportRNS
13-08-13ImmuPharma gives update on cancer programmeStockMarketWire
13-08-13UPDATE CANCER PROGRAMME IPP-204106RNS
31-07-13FDA GRANTS IMMUPHARMA AMENDED SPARNS
08-07-13ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-13ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-13IMMUPHARMA APPOINTS WORLDWIDE KEY OPINION LEADERSRNS
05-06-13Holding(s) in CompanyRNS
23-05-13Result of AGMRNS
21-05-13ImmuPharma agrees £50 financingStockMarketWire
21-05-13?50M Financing Facility - Darwin StrategicRNS
22-04-13Posting of Annual Report and AGM NoticeRNS
09-04-13ImmuPharma losses riseStockMarketWire
09-04-13Preliminary ResultsRNS
28-02-13ImmuPharma starts trading on Stuttgart ExchangeStockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory